These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 15662155)

  • 1. Adolescent weight loss during treatment with olanzapine.
    Cohen JA; Perel JM
    J Child Adolesc Psychopharmacol; 2004; 14(4):617-20. PubMed ID: 15662155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive symptoms with olanzapine.
    Alevizos B; Papageorgiou C; Christodoulou GN
    Int J Neuropsychopharmacol; 2004 Sep; 7(3):375-7. PubMed ID: 15231024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial.
    Chawla B; Luxton-Andrew H
    Hum Psychopharmacol; 2008 Apr; 23(3):211-6. PubMed ID: 18219624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine.
    Graham KA; Gu H; Lieberman JA; Harp JB; Perkins DO
    Am J Psychiatry; 2005 Sep; 162(9):1744-6. PubMed ID: 16135638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine treatment of eight adolescent patients with psychosis.
    Ercan ES; Kutlu A; Varan A; Cikoğlu S; Coşkunol H; Bayraktar E
    Hum Psychopharmacol; 2004 Jan; 19(1):53-6. PubMed ID: 14716713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
    Vieweg WV; Sood AB; Pandurangi A; Silverman JJ
    Acta Psychiatr Scand; 2005 Mar; 111(3):177-84. PubMed ID: 15701101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome--a pilot study.
    Stephens RJ; Bassel C; Sandor P
    J Child Adolesc Psychopharmacol; 2004; 14(2):255-66. PubMed ID: 15319022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine: a 5-year perspective.
    Littrell KH; Petty RG; Wolf NM
    Expert Rev Neurother; 2006 Jun; 6(6):811-21. PubMed ID: 16784405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin for weight loss in pediatric patients taking psychotropic drugs.
    Morrison JA; Cottingham EM; Barton BA
    Am J Psychiatry; 2002 Apr; 159(4):655-7. PubMed ID: 11925306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-label olanzapine treatment in five preadolescent children.
    Krishnamoorthy J; King BH
    J Child Adolesc Psychopharmacol; 1998; 8(2):107-13. PubMed ID: 9730076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic-induced weight gain: bipolar disorder and leptin.
    McIntyre RS; Mancini DA; Basile VS; Srinivasan J; Kennedy SH
    J Clin Psychopharmacol; 2003 Aug; 23(4):323-7. PubMed ID: 12920406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic-associated weight gain.
    Gentile S
    Ann Pharmacother; 2004 May; 38(5):903-4. PubMed ID: 14996995
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.
    Park YM; Cho JH; Kang SG; Choi JE; Lee SH; Kim L; Lee HJ
    J Clin Pharm Ther; 2008 Feb; 33(1):55-60. PubMed ID: 18211617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine-induced obsessive-compulsive disorder.
    Mottard JP; de la Sablonnière JF
    Am J Psychiatry; 1999 May; 156(5):799-800. PubMed ID: 10327925
    [No Abstract]   [Full Text] [Related]  

  • 19. Olanzapine-induced leucopenia and neutropenia.
    Stergiou V; Bozikas VP; Garyfallos G; Nikolaidis N; Lavrentiadis G; Fokas K
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):992-4. PubMed ID: 15950350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo.
    Baker RW; Ames D; Umbricht DS; Chengappa KN; Schooler NR
    Psychopharmacol Bull; 1996; 32(1):89-93. PubMed ID: 8927681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.